Pretta, Andrea http://orcid.org/0000-0002-0262-9270
Ziranu, Pina
Giampieri, Riccardo
Pinna, Giovanna
Randon, Giovanni
Donisi, Clelia
Ravarino, Alberto
Loi, Francesco
Deias, Giulia
Palmas, Enrico
Pretta, Gianluca
Morano, Federica
Semonella, Francesca
Mariani, Stefano
Deidda, Maria Assunta
Pusceddu, Valeria
Puzzoni, Marco
Lai, Eleonora http://orcid.org/0000-0002-0275-8187
Solinas, Cinzia
Restivo, Angelo
Zorcolo, Luigi
Barbara, Raffaele
Berardi, Rossana
Faa, Gavino
Pietrantonio, Filippo http://orcid.org/0000-0002-8530-8420
Scartozzi, Mario http://orcid.org/0000-0001-5977-5546
Article History
Received: 21 March 2023
Accepted: 14 September 2023
First Online: 25 September 2023
Competing interests
: The authors declare no competing interests.
: Ethics Committee approval was obtained for the study (Protocol number 2020/10912—code: EMIBIOCCOR) from Cagliari Independent Ethics Committee and written informed consent was obtained from all participants for their tissues to be utilized for this work. This study was performed in accordance with the study protocol, the ethical principles stated in the Declaration of Helsinki as well as those indicated in the International Conference on Harmonization (ICH) Note for Guidance on Good Clinical Practice (GCP; ICH E6, 1995), and all applicable regulatory requirements. All patients signed a written informed consent before study entry. Adequate information was given to eligible patients by the principal investigator or co-investigators in accordance with local regulations. The declaration of informed consent was personally signed and dated by the subject, and by the investigator/person designated by the investigator to conduct the informed consent discussion.
: Patients signed an informed consent regarding the publication of their data.